Vascular Medicine News

Healio and Cardiology Today have aggregated news you may have missed from the 2023 Cardiometabolic Health Congress in Boston.

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2023.

BOSTON — Data show sleep abnormalities are associated with hypertension; however, antihypertensive medications can in turn disrupt sleep, complicating treatment for patients, according to a speaker.

Patients with a history of pulmonary embolism prior to total hip or total knee arthroplasty may be at increased risk for postoperative complications and longer hospital stays, according to published results.

Patients who experienced retinal artery occlusion are at higher risk for death, stroke and myocardial infarction in both the short and long term, according to a large retrospective cohort study.

SAN FRANCISCO — A new pooled analysis showed a maintained BP-lowering effect with fewer added medications after treatment with an ultrasound renal denervation system compared with a sham procedure, a speaker reported at TCT 2023.

BOSTON — In this Healio video exclusive, Paul M. Ridker, MD, MPH, discusses the use of low-dose colchicine to target inflammation in patients who remain at high CVD risk despite controlled LDL.

BOSTON — Out-of-office BP measurements provide the clearest picture of CV risk for patients and are the ideal method to diagnose and treat hypertension, yet most clinicians still rely on inaccurate clinic readings, according to a speaker.

People infected with COVID-19 have a higher risk of cardiovascular/cerebrovascular complications. However, researchers found that these risks can be reduced with vaccination and boosting.

Adults with cannabis use disorder, or CUD, had a significantly higher risk for adverse CVD events compared with those without the disorder, a study published in Addiction found.